SAN

92.06

+2.59%↑

SHL.DE

49.22

+0.94%↑

ARGX

503

+3.65%↑

FRE

42.91

+0.73%↑

ONC.US

229.78

+2.32%↑

SAN

92.06

+2.59%↑

SHL.DE

49.22

+0.94%↑

ARGX

503

+3.65%↑

FRE

42.91

+0.73%↑

ONC.US

229.78

+2.32%↑

SAN

92.06

+2.59%↑

SHL.DE

49.22

+0.94%↑

ARGX

503

+3.65%↑

FRE

42.91

+0.73%↑

ONC.US

229.78

+2.32%↑

SAN

92.06

+2.59%↑

SHL.DE

49.22

+0.94%↑

ARGX

503

+3.65%↑

FRE

42.91

+0.73%↑

ONC.US

229.78

+2.32%↑

SAN

92.06

+2.59%↑

SHL.DE

49.22

+0.94%↑

ARGX

503

+3.65%↑

FRE

42.91

+0.73%↑

ONC.US

229.78

+2.32%↑

Search

Carl Zeiss Meditec AG

Geschlossen

BrancheGesundheitswesen

61.7 -0.08

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

60.45

Max

61.8

Schlüsselkennzahlen

By Trading Economics

Einkommen

-45M

16M

Verkäufe

-89M

491M

KGV

Branchendurchschnitt

35.311

56.602

EPS

0.36

Dividendenrendite

0.99

Gewinnspanne

3.201

Angestellte

2,066

EBITDA

-41M

37M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+2.53% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.99%

2.45%

Nächstes Ergebnis

7. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

363M

5.5B

Vorheriger Eröffnungskurs

61.78

Vorheriger Schlusskurs

61.7

Nachrichtenstimmung

By Acuity

17%

83%

24 / 382 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

Carl Zeiss Meditec AG Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

8. Apr. 2025, 08:20 UTC

Market Talk

Med-Tech Investors Seek 'Safe Havens' Amid Tariff Fears -- Market Talk

28. Okt. 2024, 11:15 UTC

Market Talk
Ergebnisse

Med-Tech Stocks Drop Amid Subdued Demand in China -- Market Talk

Peer-Vergleich

Kursveränderung

Carl Zeiss Meditec AG Prognose

Kursziel

By TipRanks

2.53% Vorteil

12-Monats-Prognose

Durchschnitt 62.75 EUR  2.53%

Hoch 86.5 EUR

Tief 41 EUR

Basierend auf 10 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Carl Zeiss Meditec AG – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

10 ratings

3

Buy

6

Halten

1

Sell

Technischer Score

By Trading Central

58.75 / 60.35Unterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

Strong Bullish Evidence

Langfristig

Weak Bearish Evidence

Stimmung

By Acuity

24 / 382 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.